[ACCESSWIRE]
LAS VEGAS, NV / ACCESSWIRE / April 18, 2016 / Biotech, was down significantly this year, with the iShares Nasdaq Biotech Index (IBB) still down almost 20%. However, it looks to be fighting its way back big time, and there are several opportunities in the biotech market to zero in on.
Probably the most exciting opportunity is, Propanc Health Group (PPCH) which is showing several bullish signals, and at 3 cents a share down about 80% from its 52 week high (which it hit right before the big biotech selloff), leaving a lot of headroom on the chart for investors to rake in profits. Up 177% off its low it seems like it's confirmed to be a bull again; the 20, 50, and 100 Day Moving Averages have all been breached to the bullish side, and the 20-50 day and 20-100 day MACD Oscillator are also positive. PPCH has the opportunity to breach several other major indicators in the coming sessions so this may be the perfect time to start research on Propanc immediately.
Here are a few other biotechs to add to your portfolio for the biotech rally:
Raptor Pharmaceuticals Corp. (RPTP) Stock closed up over 8% on Friday.
Arrowhead Pharmaceuticals, Inc. (ARWR) This stock has been making a very bullish move over the last month, let's keep an eye on it for a pullback and great entry point.
Vitae Pharmaceuticals, Inc. (VTAE) Stock has been on a very bullish uptrend.
Chimerix, Inc. (CMRX) Stock closed up nearly 4% on Friday.
Once again, at around 3 cents a share, we think Propanc Health Group (PPCH) may be the best opportunity for investors looking to benefit from the biotech bounce.
Legal Disclaimer
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. ACR Communication, LLC. which owns Microcapspeculators.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. ACR Communication, LLC. which owns, Microcapspeculators.com may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. ACR Communication LLC. which owns Microcapspeculators.com may be compensated for its services in the form of cash-based compensation or in equity in the companies it writes about, or a combination of the two. ACR Communication, LLC. has been compensated $67,000 by Propanc Health Group, Corp. for this news article and for previous as well as future news articles.
Contact:
[email protected]
SOURCE: ACR Communication, LLC
